WKN: | A2DMZL |
ISIN: | US56400P7069 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die MannKind-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 22. Juli 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2009 | 13,50 | 29,85 | 121,11% |
2 | 2020 | 1,22 | 2,64 | 116,39% |
3 | 2013 | 8,97 | 18,76 | 109,14% |
4 | 2024 | 3,33 | 6,42 | 92,79% |
5 | 2021 | 2,64 | 3,82 | 44,70% |
6 | 2019 | 0,91 | 1,22 | 34,07% |
7 | 2022 | 3,82 | 4,99 | 30,63% |
8 | 2006 | 48,70 | 61,85 | 27,00% |
9 | 2014 | 18,76 | 22,78 | 21,43% |
10 | 2010 | 29,85 | 29,66 | -0,64% |
11 | 2012 | 9,97 | 8,97 | -10,03% |
12 | 2005 | 57,15 | 48,70 | -14,79% |
13 | 2023 | 4,99 | 3,33 | -33,27% |
14 | 2017 | 3,27 | 1,98 | -39,45% |
15 | 2025 | 6,42 | 3,28 | -48,91% |
16 | 2008 | 26,60 | 13,50 | -49,25% |
17 | 2016 | 6,82 | 3,27 | -52,05% |
18 | 2018 | 1,98 | 0,91 | -54,04% |
19 | 2007 | 61,85 | 26,60 | -56,99% |
20 | 2011 | 29,66 | 9,97 | -66,39% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2015 | 22,78 | 6,82 | -70,06% |
2 | 2011 | 29,66 | 9,97 | -66,39% |
3 | 2007 | 61,85 | 26,60 | -56,99% |
4 | 2018 | 1,98 | 0,91 | -54,04% |
5 | 2016 | 6,82 | 3,27 | -52,05% |
6 | 2008 | 26,60 | 13,50 | -49,25% |
7 | 2025 | 6,42 | 3,28 | -48,91% |
8 | 2017 | 3,27 | 1,98 | -39,45% |
9 | 2023 | 4,99 | 3,33 | -33,27% |
10 | 2005 | 57,15 | 48,70 | -14,79% |
11 | 2012 | 9,97 | 8,97 | -10,03% |
12 | 2010 | 29,85 | 29,66 | -0,64% |
13 | 2014 | 18,76 | 22,78 | 21,43% |
14 | 2006 | 48,70 | 61,85 | 27,00% |
15 | 2022 | 3,82 | 4,99 | 30,63% |
16 | 2019 | 0,91 | 1,22 | 34,07% |
17 | 2021 | 2,64 | 3,82 | 44,70% |
18 | 2024 | 3,33 | 6,42 | 92,79% |
19 | 2013 | 8,97 | 18,76 | 109,14% |
20 | 2020 | 1,22 | 2,64 | 116,39% |